{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:21:21Z","timestamp":1761016881862,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":838,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.seizure.2010.11.020","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:49:59Z","timestamp":1292474999000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study"],"prefix":"10.1016","volume":"20","author":[{"given":"Yida","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2010.11.020_bib0005","first-page":"92","article-title":"Progress on the epidemiological study of epilepsy","volume":"28","author":"Zhou","year":"2007","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.seizure.2010.11.020_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-1211(00)00171-6","article-title":"Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILATV)","volume":"43","author":"Bialer","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.11.020_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-2002-36645","article-title":"Antiepileptic medications for the treatment of epilepsy","volume":"22","author":"Morrell","year":"2002","journal-title":"Semin Neurol"},{"key":"10.1016\/j.seizure.2010.11.020_bib0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2010.11.020_bib0025","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.51.5.1282","article-title":"A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77","volume":"51","author":"Chadwick","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.11.020_bib0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archneur.1995.00540340081016","article-title":"Vigabatrin vs. carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study","volume":"52","author":"Kalviainen","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2010.11.020_bib0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1528-1157.2002.20801.x","article-title":"Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis","volume":"43","author":"Marson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0040","first-page":"21","article-title":"Antiepileptic drug utilisation and seizure outcome among paediatric patients in a Malaysian public hospital","volume":"51","author":"Hasan","year":"2010","journal-title":"Singapore Med J"},{"key":"10.1016\/j.seizure.2010.11.020_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.11.020_bib0050","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.11.020_bib0055","first-page":"75","article-title":"The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies","volume":"75","author":"Nicolson","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2010.11.020_bib0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1528-1157.1997.tb01224.x","article-title":"Commission on European Affairs: appropriate standards of epilepsy care across Europe.ILEA","volume":"38","author":"Brodie","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0920-1211(95)00085-2","article-title":"A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy","volume":"23","author":"Reunanen","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.11.020_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy","volume":"107","author":"Privitera","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2010.11.020_bib0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1023\/A:1008642623460","article-title":"Better comparisons of antiepileptic drugs: what measures of efficacy?","volume":"19","author":"Chadwick","year":"1997","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.seizure.2010.11.020_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008698807530","article-title":"Evaluation of drug treatment outcome in epilepsy: a clinical perspective","volume":"19","author":"Perucca","year":"1997","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.seizure.2010.11.020_bib0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0090","first-page":"CD001031","article-title":"Lamotrigine versus carbamazepine monotherapy for epilepsy","author":"Gamble","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2010.11.020_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0105","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2165\/00003495-199652060-00008","article-title":"A practical guide to when (and how) to withdraw antiepileptic drugs in seizure-free patients","volume":"52","author":"Schmidt","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.seizure.2010.11.020_bib0110","first-page":"861","article-title":"Treatment guidelines for adult epilepsy","volume":"44","author":"Inoue","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.seizure.2010.11.020_bib0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2010.11.020_bib0120","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2010.11.020_bib0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.arcmed.2004.11.006","article-title":"Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients","volume":"36","author":"Deleu","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.seizure.2010.11.020_bib0130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/j.1528-1167.2009.02177.x","article-title":"Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study","volume":"50","author":"Cho","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.11.020_bib0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2010.11.020_bib0140","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.46.4.912","article-title":"The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal","volume":"46","author":"Walker","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.11.020_bib0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110003031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110003031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:40:10Z","timestamp":1761010810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131110003031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1059131110003031"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.11.020","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}